Your browser doesn't support javascript.
Prevalence and outcomes of re-positive nucleic acid tests in discharged COVID-19 patients.
Du, Hou-Wei; Chen, Jun-Nian; Pan, Xiao-Bin; Chen, Xiao-Ling; Fang, Shuang-Fang; Li, Xiao-Qing; Xia, Pin-Cang; Gao, Lei; Lin, Hai-Long; Chen, Li-Min; Liu, Nan.
  • Du HW; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Chen JN; Department of Critical Care Medicine, Fujian Medical University Union Hospital, Fuzhou, China.
  • Pan XB; Department of Critical Care Medicine, Fujian Provincial Hospital South Branch, Fuzhou, China.
  • Chen XL; Department of Infectious Disease, Fujian Medical University Union Hospital, Fuzhou, China.
  • Yixian-Zhang; Department of Neurology, Department of Rehabilitation, Fujian Medical University Union Hospital, 29 Xinquan Road, Gulou District, Fuzhou, 35000, China.
  • Fang SF; Department of Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Li XQ; Fujian Center for Disease Control and Prevention, Fuzhou, China.
  • Xia PC; Fujian Center for Disease Control and Prevention, Fuzhou, China.
  • Gao L; Department of Thoracic Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Lin HL; Department of Radiology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Chen LM; Department of Respiratory Medicine, Fujian Medical University Union Hospital, Fuzhou, China.
  • Liu N; Department of Neurology, Department of Rehabilitation, Fujian Medical University Union Hospital, 29 Xinquan Road, Gulou District, Fuzhou, 35000, China. xieheliunan1984@fjmu.edu.cn.
Eur J Clin Microbiol Infect Dis ; 40(2): 413-417, 2021 Feb.
Article in English | MEDLINE | ID: covidwho-737930
ABSTRACT
The prevalence and outcomes of patients who had re-activation of coronavirus disease 2019 (COVID-19) after discharge remain poorly understood. We included 126 consecutively confirmed cases of COVID-19 with 2-month follow-up data after discharge in this retrospective study. The upper respiratory specimen using a reverse-transcription polymerase chain reaction test of three patients (71 years [60-76]) were positive within 11-20 days after their discharge, with an event rate of 19.8 (95%CI 2.60-42.1) per 1,000,000 patient-days. Moreover, all re-positive patients were asymptomatic. Our findings suggest that few recovered patients may still be virus carriers even after reaching the discharge criteria.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Viral / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Eur J Clin Microbiol Infect Dis Journal subject: Communicable Diseases / Microbiology Year: 2021 Document Type: Article Affiliation country: S10096-020-04024-1

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Viral / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Eur J Clin Microbiol Infect Dis Journal subject: Communicable Diseases / Microbiology Year: 2021 Document Type: Article Affiliation country: S10096-020-04024-1